Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Manufacturing, Other
- Agriculture
- Environmental
- University / Academia / Research
- Health and Safety
- Energy
- Waste and Recycling
- Food and Beverage
- Air and Climate
- Government
- Publishing / Media / Marketing
- Glassware
- Metal
- Plastics & Resins
- Pulp & Paper
- Water and Wastewater
- Soil and Groundwater
- Construction & Construction Materials
- Mining
- Banking & Finance / Insurance / Legal
- Aerospace & Air Transport
- Forestry & Wood
- Retail
- Packaging
- Paint
- Oil, Gas & Refineries
Drug Development Suppliers & Manufacturers
406 companies found
based inBellevue, WASHINGTON (USA)
We are solving the problem of unnecessary antibacterial therapy in the treatment of middle ear infections. OtoNexus Medical Technologies´ state-of-the-art advanced ultrasound otoscope analyzes the presence and type of effusion so that primary care ...
based inYokohama, JAPAN
MabGenesis Inc. is a biopharmaceutical startup that uses 30+ years of antibody research to provide first-in-class and best-in-class therapeutic monoclonal antibody drugs for humans and animals. We have the world’s highest quality antibody libraries ...
based inShirley, NEW YORK (USA)
CD BioSciences is committed to fulfilling all your demands in the research of signaling pathways. We provide high-quality reagents, one-stop services and comprehensive solutions to support your innovative discoveries. Our mission is to provide our ...
based inDurham, NORTH CAROLINA (USA)
GeneCentric Therapeutics is applying our proprietary rT(I)ME Explorer Platform to identify high resolution molecular subtypes and drug responder populations that enable the development of precision cancer drugs while improving patient outcomes. Our ...
Pancreatic Cancer is the 11th most common cancer type with an estimated 55,000 new cases in the US in 2018, according to the United States National Cancer Institute. While it represents three percent of all cancers, pancreatic cancer is one of the ...
based inNew York City, NEW YORK (USA)
Founded in 2008, S1 Biopharma is developing first-in-class drugs for the treatment of sexual dysfunction in both women and men. The company’s non-hormonal therapies work uniquely by restoring the natural balance of neurotransmitters in the brain. ...
based inAustin, TEXAS (USA)
Lumos Pharma is a clinical-stage biopharmaceutical company whose mission is to develop new therapies for people with rare diseases, prioritizing its focus where the medical need is high, and the pathophysiology is clear. We are committed to this ...
based inPlymouth Meeting, PENNSYLVANIA (USA)
Harmony Biosciences is a commercial-stage pharmaceutical company dedicated to developing and delivering innovative therapies for people living with rare neurological diseases, especially sleep/wake, neurobehavioral, and rare epilepsy disorders. The ...
based inFoothill Ranch, CALIFORNIA (USA)
At Bal Seal Engineering, we make custom seals, springs, and electrical contacts that improve the performance and reliability of critical equipment used everywhere – from deep sea to deep space. Although they’re often measured in millimeters, our ...
based inShirley, NEW YORK (USA)
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems. We specialize in a range of formulation and drug delivery technologies, from ...
based inShirley, NEW YORK (USA)
CD Formulation is a leading manufacturer of excipients, serving the pharmaceutical industry to help it improve the performance of its products. We develop, produce and sell pharmaceutical excipients for solid, semi-solid and liquid dosage forms. Our ...
Nanoparticles have a high surface area to volume ratio, which allows them to hold a lot of material on their surface. When used as nanodrug carriers, the delivery of water-insoluble drugs is improved by delivering small particle ...
based inOttawa, ONTARIO (CANADA)
Virica was founded in 2018 based on a decade of research in the laboratory of Dr. Jean-Simon Diallo at the Ottawa Hospital Research Institute. Dr. Diallo was investigating novel oncolytic viral therapies (OVTs) and recognized the need for VSEs to ...
Gene therapies and vaccines save and protect human life. The COVID-19 pandemic highlights the criticality of vaccine development today and into the future. The pandemic also highlights the challenges drug ...
based inParis, FRANCE
Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections and cancer. As a clinical-stage company, Abivax leverages its immune enhancing and ...
based inStockholm, SWEDEN
IBT is a pharmaceutical company with its registered office in Stockholm with a vision to develop drugs influencing the human infant microbiome, and thereby prevent or treat rare diseases affecting premature infants. IBT is currently developing its ...
based inHollister, CALIFORNIA (USA)
For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across ...
From complete IND-enabling programs to stand-alone assessments, our Safety Assessment team provides a full range of in vivo and in vitro testing services and regulatory support to comply with worldwide regulatory restrictions for the nonclinical ...
based inLondon, UNITED KINGDOM
Hemogenyx Pharmaceuticals is developing breakthrough therapies for the treatment of blood diseases. Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx ...
Originally developed for in-house testing, the company’s Advanced peripheral blood Hematopoietic Chimera (“ApbHC”) is a novel type of humanised mouse that presents several advantages over existing mouse models. It ...
based inRoden, NETHERLANDS
Pure Inhalation Medication Systems (PureIMS) is a clinical stage pharmaceutical company focused on developing and commercializing innovative inhaled therapies, based on its proprietary dry powder inhaler Cyclops. The focus is on the treatment of ...
based inHørsholm, DENMARK
We are an AI-immunology platform company decoding the human immune system to discover and develop novel immunotherapies for cancer and infectious diseases. We have developed our AI-immunology core technology to deeply understand the biological ...
based inGeneve, SWITZERLAND
STALICLA has developed the first neurodevelopmental disorder-specific precision medicine discovery platform with an initial application in autism spectrum disorder (ASD). Until now, patient diagnosis and drug development for ASD and other NDDs have ...
STALICLA’s precision medicine approach begins with ‘endophenotyping’-identifying the nonbehavioral physical and molecular presentations of NDDs and characterizing subgroups of patients with similar disease signatures. DEPI matches ...
based inDerio - Bizkaia, SPAIN
We are experts in screening, drug discovery and biomolecule characterization employing tools based in our propietary microarray technology. We offer a variety full analytical services as well as development of customized tools suited to your ...
based inMetropolitan (Doryong-dong), SOUTH KOREA
Founded in February 1997, B&B Co., Ltd. is a university, pharmaceutical company, industry, government-funded research institute, and bio venture that strives to research analysis equipment and reagents related to life science for domestic life ...
